Investors
Biocon Biologics  /  Investors  /  Corporate Governance  /  Board Committees

BOARD COMMITTEES

The Company has constituted a qualified independent Audit Committee, which acts as a link between the Management, External and Internal Auditors and the Board of Directors of the Company. The Audit Committee considers the matters which are specifically referred to it by the Board of Directors besides considering the mandatory requirements of the provisions of Section 177 of the Act. The key responsibilities of the Committee include review of the financial statements before submission to the Board, approval or any subsequent modification of transactions with related parties, oversight of the financial reporting process to ensure transparency, sufficiency, recommendation for appointment, remuneration and terms of appointment of auditors of the Company etc. The Committee also reviews the adequacy and effectiveness of internal audit function and control systems.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Mr. Bobby Kanubhai Parikh, Chairperson

– Dr. Arun Suresh Chandavarkar

– Mr. John Russell Fotheringham Walls

– Mr. Daniel Mark Bradbury

Link to the charter of the committee

The Nomination and Remuneration Committee reviews, acts on and reports to the Board with respect to various governance, nomination, compensation and performance evaluation matters. The Committee works with full autonomy and is free of any managerial interference.

The key authorities with which the Committee is vested with are given hereunder:

  1. to recommend nominations for Board membership;
  2. succession planning for the senior management and the Board;
  3. to develop and recommend policies with respect to composition of the Board commensurate with the size, nature of the business and operations of the Company;
  4. to establish criteria for selection of Board Members with respect to competencies; qualifications, experience, track record, integrity, devise appropriate succession plans;
  5. to recommend to the Board, policies relating to the remuneration of Directors, Key Managerial Personnel and Senior Management;
  6. laying down of performance parameters for the Chairperson and Managing Director, the Executive Director(s), Key Managerial Personnel and Senior Management;
  7. formulates the criteria for determining qualifications, positive attributes and independence of a Director; and
  8. to determine overall compensation policies of the Company, etc.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Ms. Nivruti Rai, Chairperson

– Mr. Peter Baron Piot

– Mr. Daniel Mark Bradbury

– Mr. Thomas Jason Roberts

Link to the charter of the committee

The scope of this Committee is to assist the Board of Directors in timely identification, assessment and mitigation of risks (i.e. financial, operational, strategic, regulatory, statutory, reputational, political, catastrophic and others) faced by the Company. The Committee has overall responsibility for monitoring and approving the enterprise risk management framework and is capable of effectively addressing and monitoring these risks etc. The Committee also approves and oversees a Company-wide risk management framework, capable of effectively addressing these risks.

The Committee is constituted as per the regulatory norms and comprises of the following members:

– Mr. Bobby Kanubhai Parikh, Chairperson

– Mr. Shreehas Pradeep Tambe

– Mr. Arun Suresh Chandavarkar

– Mr. John Russell Fotheringham Walls

– Mr. Daniel Mark Bradbury

– Mr. Thomas Jason Roberts

– Mr. Peter Baron Piot

Link to the charter of the committee

The prime responsibility of this Committee is to assist the Board in discharging its social responsibilities by way of formulating, monitoring and implementing a framework in line with the Corporate Social Responsibility Policy of the Company.

The key terms of reference of the CSR and ESG Committee are in line with the provisions of Section 135 of the Act, which inter alia includes the following:

  1. Identifying the areas of CSR activities, its implementation and monitoring;
  2. Formulate and amend the CSR Policy, from time to time;
  3. Adoption of Annual Action Plan or modification thereof;
  4. Oversee Company’s ESG program, strategy, initiatives, execution and disclosures; and
  5. Reporting progress of various initiatives with respect to CSR & ESG activities etc.

Reporting progress of various initiatives with respect to CSR & ESG activities etc.

– Mr. Peter Baron Piot, Chairperson

– Ms. Kiran Mazumdar-Shaw

– Mr. Shreehas Pradeep Tambe

– Ms. Nivruti Rai

– Mr. Thomas Jason Roberts

Link to the charter of the committee

Share